TMEM16A/ANO1 calcium-activated chloride channel as a novel target for the treatment of human respiratory syncytial virus infection

Pearson, H orcid.org/0000-0001-6591-9884, Todd, EJAA orcid.org/0000-0003-0011-262X, Ahrends, M et al. (10 more authors) (2021) TMEM16A/ANO1 calcium-activated chloride channel as a novel target for the treatment of human respiratory syncytial virus infection. Thorax, 76 (1). pp. 64-72. ISSN 0040-6376

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © Author(s) (or their employer(s)) 2020. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/)
Dates:
  • Published: January 2021
  • Accepted: 15 September 2020
  • Published (online): 27 October 2020
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Biological Sciences (Leeds) > School of Biomedical Sciences (Leeds)
The University of Leeds > Faculty of Biological Sciences (Leeds) > School of Molecular and Cellular Biology (Leeds) > Molecular Biology (Leeds)
Funding Information:
FunderGrant number
Royal SocietyRG110306
Royal SocietyUF100419
British Lung FoundationPPRG15-17
Depositing User: Symplectic Publications
Date Deposited: 16 Sep 2020 15:31
Last Modified: 10 Nov 2021 13:42
Status: Published
Publisher: BMJ Publishing Group
Identification Number: https://doi.org/10.1136/thoraxjnl-2020-215171

Share / Export

Statistics